Individual stress vulnerability is predicted by short-term memory and AMPA receptor subunit ratio in the hippocampus

Journal of Neuroscience

Volumn 30, Issue 50, 2010, Pages 16949-16958

  Schmidt, Mathias V ^a   Trümbach, Dietrich ^b   Weber, Peter ^a   Wagner, Klaus ^a   Scharf, Sebastian H ^a   Liebl, Claudia ^a   Datson, Nicole ^d   Namendorf, Christian ^a   Gerlach, Tamara ^a   Kühne, Claudia ^a   Uhr, Manfred ^a   Deussing, Jan M ^a   Wurst, Wolfgang ^a,b,c   Binder, Elisabeth B ^a   Holsboer, Florian ^a   Müller, Marianne B ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^d LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GLUR1 GENE; HIPPOCAMPUS; MALE; MOUSE; NEUROENDOCRINOLOGY; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SHORT TERM MEMORY; SOCIAL STRESS; STRESS;

ANIMALS; CORTICOSTERONE; DEPRESSIVE DISORDER, MAJOR; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; GENETIC TESTING; HIPPOCAMPUS; INDIVIDUALITY; MALE; MEMORY, SHORT-TERM; MICE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ARRAY ANALYSIS; RECEPTORS, AMPA; RESILIENCE, PSYCHOLOGICAL; RISK FACTORS; STRESS, PSYCHOLOGICAL; SULFONAMIDES;

EID: 78650368828     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4668-10.2010     Document Type: Article

References (53)

1. Alt A, Nisenbaum ES, Bleakman D, Witkin JM (2006) A role for AMPA receptors in mood disorders. Biochem Pharmacol 71:1273-1288.
2. Arai AC, Kessler M (2007) Pharmacology of ampakine modulators: from AMPA receptors to synapses and behavior. Curr Drug Targets 8:583-602.
3. Bai F, Li X, Clay M, Lindstrom T, Skolnick P (2001) Intra- and interstrain differences in models of "behavioral despair." Pharmacol Biochem Behav 70:187-192.
4. Bai F, Bergeron M, Nelson DL (2003) Chronic AMPA receptor potentiator (LY451646) treatment increases cell proliferation in adult rat hippocampus. Neuropharmacology 44:1013-1021.
5. Barbon A, Popoli M, La Via L, Moraschi S, Vallini I, Tardito D, Tiraboschi E, Musazzi L, Giambelli R, Gennarelli M (2006) Regulation of editing and expression of glutamate [alpha]-amino-propionic-acid (AMPA)/kainate receptors by antidepressant drugs. Biol Psychiatry 59:713-720.
6. Bleakman D, Alt A, Witkin JM (2007) AMPA receptors in the therapeutic management of depression. CNS Neurol Disord Drug Targets 6:117-126.
7. Charney DS (1998) Monoamine dysfunction and the pathophysiology and treatment of depression. J Clin Psychiatry 59 [Suppl 14]:11-14.
8. Chourbaji S, Vogt MA, Fumagalli F, Sohr R, Frasca A, Brandwein C, Hörtnagl H, Riva MA, Sprengel R, Gass P (2008) AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression. FASEB J 22:3129-3134.
9. Chudin E, Kruglyak S, Baker SC, Oeser S, Barker D, McDaniel TK (2006) A model of technical variation of microarray signals. J Comput Biol 13:996-1003.
10. Datson NA, Meijer L, Steenbergen PJ, Morsink MC, van der LS, Meijer OC, De Kloet ER (2004) Expression profiling in laser-microdissected hippocampal subregions in rat brain reveals large subregion-specific differences in expression. Eur J Neurosci 20:2541-2554. (Pubitemid 39573770)
11. Du J, Gray NA, Falke CA, Chen W, Yuan P, Szabo ST, Einat H, Manji HK (2004) Modulation of synaptic plasticity by antimanic agents: the role of AMPA glutamate receptor subunit 1 synaptic expression. J Neurosci 24:6578-6589. (Pubitemid 38971707)
12. Fanselow MS, Dong HW (2010) Are the dorsal and ventral hippocampus functionally distinct structures? Neuron 65:7-19.
13. Farley S, Apazoglou K, Witkin JM, Giros B, Tzavara ET (2010) Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm. Int J Neuropsychopharmacol 13:1207-1218.
14. Fluttert M, Dalm S, Oitzl MS (2000) A refined method for sequential blood sampling by tail incision in rats. Lab Anim 34:372-378.
15. Freed WJ, Dillon-Carter O, Kleinman JE (1993) Properties of [3H]AMPA binding in postmortem human brain from psychotic subjects and controls: increases in caudate nucleus associated with suicide. Exp Neurol 121:48-56.
16. Gates M, Ogden A, Bleakman D (2001) Pharmacological effects of AMPA receptor potentiators LY392098 and LY404187 on rat neuronal AMPA receptors in vitro. Neuropharmacology 40:984-991. (Pubitemid 32530604)
17. Hashimoto K (2009) Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res Rev 61:105-123.
18. Heine M, Groc L, Frischknecht R, Beique JC, Lounis B, Rumbaugh G, Huganir RL, Cognet L, Choquet D (2008) Surface mobility of postsynaptic AMPARs tunes synaptic transmission. Science 320:201-205. (Pubitemid 351521410)
19. Huynh NN, McIntyre RS (2008) What are the implications of the STAR*D trial for primary care? A review and synthesis. Prim Care Companion J Clin Psychiatry 10:91-96.
20. Isaac JTR, Ashby M, McBain CJ (2007) The role of the GluR2 subunit in AMPA receptor function and synaptic plasticity. Neuron 54:859-871. (Pubitemid 46907505)
21. Izquierdo LA, Barros DM, Vianna MR, Coitinho A, deDavid e Silva, Choi H, Moletta B, Medina JH, Izquierdo I (2002) Molecular pharmacological dissection of short- and long-term memory. Cell Mol Neurobiol 22:269-287.
22. Kendler KS, Kessler RC, Walters EE, MacLean C, Neale MC, Heath AC, Eaves LJ (1995) Stressful life events, genetic liability, and onset of an episode of major depression in women. Am J Psychiatry 152:833-842.
23. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS (2003) The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCSR). JAMA 289:3095-3105. (Pubitemid 37432885)
24. Kim JS, Schmid-Burgk W, Claus D, Kornhuber HH (1982) Increased serum glutamate in depressed patients. Arch Psychiatr Nervenkr 232:299-304. (Pubitemid 13124834)
25. Li X, Tizzano JP, Griffey K, Clay M, Lindstrom T, Skolnick P (2001) Antidepressant-like actions of an AMPA receptor potentiator (LY392098). Neuropharmacology 40:1028-1033. (Pubitemid 32530609)
26. Li X, Witkin JM, Need AB, Skolnick P (2003) Enhancement of antidepressant potency by a potentiator of AMPA receptors. Cell Mol Neurobiol 23:419-430.
27. Liu HH, Payne HR, Wang B, Brady ST (2006) Gender differences in response of hippocampus to chronic glucocorticoid stress: role of glutamate receptors. J Neurosci Res 83:775-786.
28. Machado-Vieira R, Manji HK, Zarate CA (2009) The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders. Neuroscientist 15:525-539.
29. Mackowiak M, O'Neill MJ, Hicks CA, Bleakman D, Skolnick P (2002) An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study. Neuropharmacology 43:1-10.
30. Maeng CA, Zarate CA (2007) The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. Curr Psychiatry Rep 9:467-474.
31. Maeng S, Zarate CA, Du J, Schloesser RJ, McCammon J, Chen G, Manji HK (2008) Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry 63:349-352.
32. Mannie ZN, Harmer CJ, Cowen PJ, Norbury R (2010) A functional magnetic resonance imaging study of verbal working memory in young people at increased familial risk of depression. Biol Psychiatry 67:471-477.
33. Martin S, Henley JM, Holman D, Zhou M, Wiegert O, van Spronsen M, Joels M, Hoogenraad CC, Krugers HJ (2009) Corticosterone alters AMPAR mobility and facilitates bidirectional synaptic plasticity. PLoS One 4:e4714.
34. Meador-Woodruff JH, Hogg AJ, Smith RE (2001) Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder. Brain Res Bull 55:631-640.
35. Merali Z, Levac C, Anisman H (2003) Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice. Biol Psychiatry 54:552-565.
36. Mitani H, Shirayama Y, Yamada T, Maeda K, Ashby CR, Kawahara R (2006) Correlation between plasma levels of glutamate, alanine and serine with severity of depression. Prog Neuropsychopharmacol Biol Psychiatry 30:1155-1158.
37. Miu P, Jarvie KR, Radhakrishnan V, Gates MR, Ogden A, Ornstein PL, Zarrinmayeh H, Ho K, Peters D, Grabell J, Gupta A, Zimmerman DM, Bleakman D (2001) Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro. Neuropharmacology 40:976-983. (Pubitemid 32530603)
38. O'Neill MJ, Witkin JM (2007) AMPA receptor potentiators: application for depression and Parkinson's disease. Curr Drug Targets 8:603-620.
39. Ozbay F, Fitterling H, Charney D, Southwick S (2008) Social support and resilience to stress across the life span: a neurobiologic framework. Curr Psychiatry Rep 10:304-310.
40. Quirk JC, Nisenbaum ES (2002) LY404187: a novel positive allosteric modulator of AMPA receptors. CNS Drug Rev 8:255-282.
41. Rao VR, Finkbeiner S (2007) NMDA and AMPA receptors: old channels, new tricks. Trends Neurosci 30:284-291.
42. Sanacora G, Zarate CA, Krystal JH, Manji HK (2008) Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov 7:426-437.
43. Sanderson DJ, Good MA, Skelton K, Sprengel R, Seeburg PH, Rawlins JN, Bannerman DM (2009) Enhanced long-term and impaired short-term spatial memory in GluA1 AMPA receptor subunit knockout mice: evidence for a dual-process memory model. Learn Mem 16:379-386.
44. Sawada J, Yamashita T, Aizawa H, Aburakawa Y, Hasebe N, Kwak S (2009) Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line. Neurosci Res 64:251-258.
45. Schmidt MV, Sterlemann V, Ganea K, Liebl C, Alam S, Harbich D, Greetfeld M, Uhr M, Holsboer F, Müller MB (2007) Persistent neuroendocrine and behavioral effects of a novel, etiologically relevant mouse paradigm for chronic social stress during adolescence. Psychoneuroendocrinology 32:417-429.
46. Schmidt MV, Scharf SH, Sterlemann V, Ganea K, Liebl C, Holsboer F, Müller MB (2009) High susceptibility to chronic social stress is associated with a depression-like phenotype. Psychoneuroendocrinology 35:635-643.
47. Schmitt WB, Sprengel R, Mack V, Draft RW, Seeburg PH, Deacon RMJ, Rawlins JNP, Bannerman DM (2005) Restoration of spatial working memory by genetic rescue of GluR-A-deficient mice. Nat Neurosci 8:270-272.
48. Simoes PF, Silva AP, Pereira FC, Marques E, Grade S, Milhazes N, Borges F, Ribeiro CF, Macedo TR (2007) Methamphetamine induces alterations on hippocampal NMDA and AMPA receptor subunit levels and impairs spatial working memory. Neuroscience 150:433-441.
49. Su XW, Li XY, Banasr M, Koo JW, Shahid M, Henry B, Duman RS (2009) Chronic treatment with AMPA receptor potentiator Org 26576 increases neuronal cell proliferation and survival in adult rodent hippocampus. Psychopharmacology 206:215-222.
50. Svenningsson P, Bateup H, Qi H, Takamiya K, Huganir RL, Spedding M, Roth BL, McEwen BS, Greengard P (2007) Involvement of AMPA receptor phosphorylation in antidepressant actions with special reference to tianeptine. Eur J Neurosci 26:3509-3517.
51. Vandergriff J, Huff K, Bond A, Lodge D (2001) Potentiation of responses to AMPA on central neurones by LY392098 and LY404187 in vivo. Neuropharmacology 40:1003-1009.
52. Wang J (2005) Work stress as a risk factor for major depressive episode(s). Psychol Med 35:865-871.
53. Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856-864.